Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

ClinicalTrials.gov ID: NCT00730405

Public ClinicalTrials.gov record NCT00730405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the Efficacy and Safety of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 2 study to examine how the study drug works and its side effects in subjects with toenail fungus.

Study identification

NCT ID
NCT00730405
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Stiefel, a GSK Company
Industry
Enrollment
582 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2008
Primary completion
Feb 18, 2010
Completion
Feb 18, 2010
Last update posted
Mar 11, 2018

2008 – 2010

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Genova Clinical Research Tucson Arizona 85791
Impact Clinical Trials Beverly Hills California 90211
Northern California Research Carmichael California 95608
Center for Dermatology Clinical Research Fremont California 94538
Therapeutics Clinical Research San Diego California 92123
UCSF Dermatology Research San Francisco California 94115
Thomas J. Stephens & Associates, Inc. Colorado Research Center Colorado Springs Colorado 80915
International Dermatology Research Inc Miami Florida 33144
Greater Miami Skin & Laser Center Miami Beach Florida 33140
Miami Dermatology Research Institute LLC North Miami Beach Florida 33169
MedaPhase, Inc Newnan Georgia 30263
Gwinnett Clinical Research Center, Inc. Snellville Georgia 30078
Welborn Clinic Evansville Indiana 47713
Henry Ford Medical Center Detroit Michigan 48202
Minnesota Clinical Study Center Fridley Minnesota 55432
Skin Specialists, Inc Omaha Nebraska 68144
NYU Medical Center New York New York 10016
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Oregon Dermatology & Research Centre Portland Oregon 97210
Oregon Medical Portland Oregon 97223
The Skin Wellness Center Knoxville Tennessee 37922
Tennessee Clinical Research Nashville Tennessee 37215
DermResearch, Inc. Austin Texas 78759
J & S Studies, Inc. College Station Texas 77845
Research Across America Dallas Texas 75234
Center for Clinical Studies Houston Texas 77058
DermatologyResearch Center Salt Lake City Utah 84124
Education and Research Foundation Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00730405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2018 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00730405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →